Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
Clinical trial NCT03481634 · COMPLETED
Trial details
- NCT number
- NCT03481634
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-23
- Primary completion
- 2020-11-11
- Enrollment
- 566
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.